Literature DB >> 34144276

Artematrovirenins A-P, guaiane-type sesquiterpenoids with cytotoxicities against two hepatoma cell lines from Artemisia atrovirens.

Li-Hua Su1, Yun-Bao Ma2, Chang-An Geng2, Tian-Ze Li2, Xiao-Yan Huang2, Jing Hu2, Shuang Tang1, Cheng Shen1, Zhen Gao1, Xue-Mei Zhang2, Ji-Jun Chen3.   

Abstract

Random screening revealed that the EtOH extract of Artemisia atrovirens showed significant cytotoxicity against two human hepatoma cell lines (HepG2 and Huh7) with the inhibitory ratio of 98.9% and 99.7% at the concentration of 100 μg/mL. Further bioactivity-guided isolation of active fraction led to 16 new guaiane-type sesquiterpenoids, artematrovirenins A-P (1-16). Their structures were elucidated by extensive spectroscopic data. The absolute stereochemistry of compounds 1 and 14 was determined by single-crystal X-ray diffraction analyses. Pharmacological evaluation suggested that five compounds (3, 5, 8, 10, and 15) exhibited cytotoxicity, compounds 3 and 5 displayed cytotoxicity against HepG2 cell line with an IC50 values of 8.0 and 16.0 μM, as well as against Huh7 cell line with values of 18.2 and 32.2 μM.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artemisia atrovirens; HepG2 and Huh7 cell lines; antihepatic cytotoxicity; artematrovirenins A−P; guaiane-type sesquiterpenoids

Mesh:

Substances:

Year:  2021        PMID: 34144276     DOI: 10.1016/j.bioorg.2021.105072

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  Design and synthesis of ludartin derivatives as potential anticancer agents against hepatocellular carcinoma.

Authors:  Jin-Jin Sun; Jin-Ping Wang; Tian-Ze Li; Yun-Bao Ma; Dong Xue; Ji-Jun Chen
Journal:  Med Chem Res       Date:  2022-05-24       Impact factor: 2.351

2.  Artemyrianosins A-J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha.

Authors:  Xin Zhang; Yun-Bao Ma; Xiao-Feng He; Tian-Ze Li; Chang-An Geng; Li-Hua Su; Shuang Tang; Zhen Gao; Ji-Jun Chen
Journal:  Nat Prod Bioprospect       Date:  2022-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.